Successful treatment and secondary prophylaxis with pritelivir for a recurrent multi-drug resistant HSV-1 infection in an allogeneic hematopoietic stem cell transplant recipient.

pritelivir (AIC316) - AiCuris

Successful treatment and secondary prophylaxis with pritelivir for a recurrent multi-drug resistant HSV-1 infection in an allogeneic hematopoietic stem cell transplant recipient. (PubMed, Clin Microbiol Infect) - Apr 27, 2025 - No abstract available
Journal • Bone Marrow Transplantation • Infectious Disease • Transplantation

http://www.ncbi.nlm.nih.gov/pubmed/40258442

; Bartoletti Michele; Birkmann Alexander; Bussini Linda; Giardina Federica Am; Mannina Daniele; Paolucci Stefania

Apr 27, 2025